A detailed history of Russell Investments Group, Ltd. transactions in Personalis, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 16,504 shares of PSNL stock, worth $70,967. This represents 0.0% of its overall portfolio holdings.

Number of Shares
16,504
Previous 18,644 11.48%
Holding current value
$70,967
Previous $21,000 319.05%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1.19 - $6.34 $2,546 - $13,567
-2,140 Reduced 11.48%
16,504 $88,000
Q2 2024

Aug 08, 2024

SELL
$1.17 - $1.65 $2,925 - $4,125
-2,500 Reduced 11.82%
18,644 $21,000
Q1 2024

May 08, 2024

SELL
$1.15 - $2.19 $1,253 - $2,387
-1,090 Reduced 4.9%
21,144 $31,000
Q4 2023

Feb 05, 2024

SELL
$0.93 - $2.35 $1,506 - $3,807
-1,620 Reduced 6.79%
22,234 $46,000
Q3 2023

Nov 13, 2023

SELL
$1.19 - $2.36 $1,556 - $3,086
-1,308 Reduced 5.2%
23,854 $28,000
Q2 2023

Aug 10, 2023

BUY
$1.8 - $3.19 $1,753 - $3,107
974 Added 4.03%
25,162 $47,000
Q1 2023

May 09, 2023

SELL
$2.01 - $4.17 $1,370 - $2,843
-682 Reduced 2.74%
24,188 $66,000
Q4 2022

Feb 08, 2023

BUY
$1.78 - $3.64 $24,279 - $49,649
13,640 Added 121.46%
24,870 $49,000
Q3 2022

Nov 04, 2022

SELL
$2.89 - $5.32 $6,025 - $11,092
-2,085 Reduced 15.66%
11,230 $33,000
Q2 2022

Jul 29, 2022

SELL
$3.27 - $8.76 $5,179 - $13,875
-1,584 Reduced 10.63%
13,315 $45,000
Q1 2022

May 05, 2022

BUY
$7.56 - $14.3 $112,636 - $213,055
14,899 New
14,899 $121,000
Q4 2021

Jan 21, 2022

SELL
$12.24 - $21.25 $155,448 - $269,875
-12,700 Closed
0 $0
Q3 2021

Nov 08, 2021

BUY
$16.69 - $26.05 $211,963 - $330,835
12,700 New
12,700 $244,000
Q3 2020

Nov 09, 2020

SELL
$13.63 - $24.12 $95,505 - $169,008
-7,007 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$7.65 - $14.11 $53,603 - $98,868
7,007 New
7,007 $90,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $197M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Russell Investments Group, Ltd. Portfolio

Follow Russell Investments Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.